Biocatalysts Builds Specialty Enzyme Factory
The company says it can make high-activity enzymes on a large commercial scale.
Biocatalysts Ltd. (Bensenville, IL) is building what it says is a unique production plant for specialty intracellular enzymes. The new plant improves efficiency of production for an otherwise costly and troublesome process.
The company says that while today’s enzymes can be easy to produce in large batches, its specialty enzymes undergo a cell breaker process that releases the enzyme from its sludge after fermentation. While producing these enzymes is possible in small-scale operations, large-scale operations have traditionally been viewed as quite challenging, if not impossible. Now, Biocatalysts says its new plant can produce batches of up to hundreds of kilograms of high-activity, freeze-dried enzymes.
“In the past, customers would go to a contract research company for enzyme development and then look for a contract manufacturing company to make the enzyme,” says Stuart West, Biocatalysts managing director. “Having all this under one roof enables us to develop novel enzymes very rapidly and cost-effectively.”
The Nutritional Outlook Podcast Episode 39: Nutritional Outlook's Ingredients to Watch in 2025
February 25th 2025In this episode, Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2025.
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
